Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Fulgent Genetics United States | 70 | 26 |
|
Full Comprehensive Cancer Panel Fulgent Genetics United States | 329 | 127 |
|
Nervous System / Brain Cancer Comprehensive Panel Fulgent Genetics United States | 133 | 27 |
|
Comprehensive Hereditary Cancer Panel Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 128 | 130 |
|
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics Children's Hospital of Philadelphia United States | 2 | 240 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 27 | 26 |
|
Invitae Nervous System/Brain Cancer Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 30 | 25 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 138 | 80 |
|
CeGaT GmbH Germany | 3 | 1 |
|
Hemato-oncology chromosomal microarray Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 23 | 93 |
|
Hereditary Cancer Panel, Sequencing and Deletion/Duplication ARUP Laboratories, Molecular Genetics and Genomics ARUP Laboratories United States | 33 | 73 |
|
Asper Biogene Asper Biogene LLC Estonia | 135 | 98 |
|
Fulgent Genetics United States | 3 | 1 |
|
Invitae Basal Cell Nevus Syndrome Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 2 | 2 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
Hereditary onco-endocrino tumors (50 genes) Center for Human Genetics Cliniques Universitaires Saint Luc Belgium | 25 | 49 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.